臓器オンチップ市場の市場規模、シェア、動向分析レポート：製品・サービス別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

臓器チップ市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の臓器オンチップ市場規模は2030年までに9億5,240万米ドルに達すると予測されています。

市場は2025～2030年にかけて35.11％のCAGRを記録すると予測されています。慢性疾患の有病率の増加、創薬ニーズの高まり、民間と公的参入企業からの投資や資金調達の増加などの要因が、市場成長を促進すると予想されます。また、製薬・バイオテクノロジー企業や学術・研究機関からの需要の高まりによる市場競争の激化も、予測期間中の産業成長を促進すると予想されます。

さらに、効率的な創薬技術に対する需要の高まり、特に慢性疾患の有病率上昇の背景が、市場成長の原動力となっています。例えば、2023年7月、NETRIはAxion BioSystemsと提携し、中東・アフリカラインの発売を発表しました。この製品ラインは、AxionのMaestro MultiElectrode Array（MEA）システムと互換性があり、中東・アフリカ層を備えたユニークなコンパートメント型マイクロ流体機器を紹介しています。これらのすぐに使用可能なプラットフォームは、臓器オンチップ用途のための高スループットソリューションを提供し、神経学、皮膚科学、疾患研究や創薬に重要な他のセグメントにおける先進的研究を促進します。

さらに、肝臓オンチップセグメントは、生物医療研究と医薬品開発を進める上で重要な役割を果たすことから、臓器オンチップ産業の重要な牽引役となっています。例えば、2023年9月、臓器オンチップ産業の主要参入企業であるCN Bioは、全ヒト研究ソリューションの専門知識で世界的に認知されている非営利団体LifeNet Health LifeSciences社と提携しました。この提携は、CN BioのフィジオミミックスOOCシリーズにLifeNet Healthの検証済み初代ヒト細胞を供給することを目的としています。この契約において、LifeNet Healthは、CN Bioの非アルコール性脂肪肝炎（NASH）用「in-a-box」キットを通じて、あるいはLifeNet Healthから直接入手できる、最高品質のMPS検証済み肝細胞を提供しました。

さらに、北米は2023年に臓器オンチップ産業を支配し、予測期間中に最も速いCAGRで成長すると予測されています。この成長の背景には、同地域の主要市場参入企業の存在と政府の取り組みがあります。例えば、2023年3月、Bayer AGはesqLABSとDynamic42と提携しました。彼らは、医療産業における医薬品開発のための動物実験を減らすために、1年間の臓器オンチップパイロットプログラムを導入しました。このようなビジネスイニシアチブは、北米地域の市場成長に貢献すると予想されます。

臓器チップ市場レポートハイライト

• 2024年の収益シェアは、サービスセグメントが52.18%で最大となっています。このセグメントの成長は、専門的な専門知識、費用対効果、包括的なソリューションを提供できることに起因しています。
• 創薬セグメントは、前臨床検査を進める上で重要な役割を果たすため、2024年の売上高シェアは62.78%で市場を独占しました。
• 北米の臓器オンチップ市場は2024年に51.97%の収益シェアで世界市場を独占しています。
• アジア太平洋の臓器オンチップ市場は、予測期間中に29.11%の最速成長率が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 産業分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 製品・サービスビジネス分析

• 製品・サービスセグメントダッシュボード
• 臓器チップ市場の製品・サービスの変動分析
• 臓器チップ市場規模と動向分析、製品・サービス別、2018～2030年
• 製品
  • 製品市場推定・予測、2018～2030年
  • 機器
  • 臓器チップデバイス
• サービス
  • サービス市場推定・予測、2018～2030年

第5章 用途ビジネス分析

• 用途セグメントダッシュボード
• 臓器オンチップ市場の用途変動分析
• 臓器オンチップ市場規模と動向分析、用途別、2018～2030年
• 創薬
  • 創薬市場推定・予測、2018～2030年
• 毒性学研究
  • 毒物学研究市場推定・予測、2018～2030年
• その他
  • その他市場推定・予測、2018～2030年

第6章 最終用途ビジネス分析

• 最終用途セグメントダッシュボード
• 臓器チップ市場の最終用途変動分析
• 臓器オンチップ市場規模と動向分析、最終用途別、2018～2030年
• 製薬とバイオテクノロジー企業
  • 製薬とバイオテクノロジー企業の市場推定・予測、2018～2030年
• 学術研究機関
  • 学術研究機関市場推定・予測、2018～2030年
• その他
  • その他市場推定・予測、2018～2030年

第7章 製品・サービス、用途、最終用途別の地域ビジネス分析

• 地域ダッシュボード
• 市場規模と予測と動向分析、2024年と2030年
• 北米
  • 北米の臓器チップ市場、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の臓器チップ市場、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の臓器チップ市場、2018～2030年
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの臓器チップ市場、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの臓器チップ市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2024年
• 企業プロファイル/上場企業
  • Emulate, Inc.
  • MIMETAS BV
  • Valo Health
  • Nortis, Inc.
  • AxoSim
  • BICO-THE BIO CONVERGENCE COMPANY
  • CN Bio Innovations Ltd
  • The Charles Stark Draper Laboratory, Inc.
  • SynVivo, Inc.
  • AlveoliX AG

List of Tables

• Table 1 List of abbreviation
• Table 2 Global organ-on-a-chip market, by region, 2018 - 2030 (USD Million)
• Table 3 Global organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 4 Global organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 5 Global organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America organ-on-a-chip market, by country, 2018 - 2030 (USD Million)
• Table 7 North America organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 8 North America organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 9 North America organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 11 U.S. organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 14 Canada organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 17 Mexico organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe organ-on-a-chip market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 21 Europe organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 24 Germany organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 25 Germany organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 26 UK organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 27 UK organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 28 UK organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 29 France organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 30 France organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 31 France organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 33 Italy organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 36 Spain organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 39 Denmark organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 40 Denmark organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 42 Sweden organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 44 Norway organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 45 Norway organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 46 Norway organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific organ-on-a-chip market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 51 China organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 52 China organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 53 China organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 54 Japan organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 55 Japan organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 56 Japan organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 57 India organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 58 India organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 59 India organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 60 South Korea organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 61 South Korea organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 62 South Korea organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 63 Australia organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 64 Australia organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 65 Australia organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 67 Thailand organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America organ-on-a-chip market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 71 Latin America organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 74 Brazil organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 77 Argentina organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middel East & Africa organ-on-a-chip market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 84 South Africa organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 90 UAE organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait organ-on-a-chip market, by products & service, 2018 - 2030 (USD Million)
• Table 93 Kuwait organ-on-a-chip market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait organ-on-a-chip market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Organ-on-a-chip market: market outlook
• Fig. 7 Organ-on-a-chip competitive insights
• Fig. 8 Parent market outlook
• Fig. 9 Organ-on-a-chip market driver impact
• Fig. 10 Organ-on-a-chip market restraint impact
• Fig. 11 Organ-on-a-chip market: Products & service movement analysis
• Fig. 12 Organ-on-a-chip market: Products & service outlook and key takeaways
• Fig. 13 Products market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Organ-on-a-chip devices market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 16 Liver-on-a-chip market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 17 Lung-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Intestine-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Kidney-on-a-chip market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 20 Heart-on-a-chip market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 21 Others market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 22 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Organ-on-a-chip market: Application movement analysis
• Fig. 24 Organ-on-a-chip market: Application outlook and key takeaways
• Fig. 25 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 26 Toxicology research market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 27 Others market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 28 Organ-on-a-chip market: End use movement analysis
• Fig. 29 Organ-on-a-chip market: End use outlook and key takeaways
• Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 31 Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 North America organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 U.S. organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Canada organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Mexico organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Europe organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 UK organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Germany organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 France organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Italy organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Spain organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Denmark organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Sweden organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Norway organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Asia Pacific organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 China organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Japan organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 India organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Thailand organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 South Korea organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Australia organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Latin America organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Brazil organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Argentina organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Middle East and Africa organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 South Africa organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Saudi Arabia organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 UAE organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Kuwait organ-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Market share of key market players - Organ-on-a-chip market

Organ-on-a-chip Market Growth & Trends:

The global organ-on-a-chip market size is anticipated to reach USD 952.4 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to register a CAGR of 35.11% from 2025 to 2030. Factors such as the increasing prevalence of chronic disease, the rising need for drug discovery, and growing investment and funding from private and public players are expected to drive the market growth. In addition, increasing competition in the market owing to rising demand from pharmaceutical & biotechnology companies and academic & research institutions is also anticipated to propel the industry growth over the forecast period.

Moreover, the increasing demand for efficient drug discovery techniques, particularly in the context of the rising prevalence of chronic diseases is driving the market growth. For instance, in July 2023, NETRI, in partnership with Axion BioSystems, announced the launch of the NeuroFluidics MEA line. This product line, compatible with Axion's Maestro MultiElectrode Array (MEA) systems, introduces a unique range of compartmentalized microfluidic instruments with an MEA layer. These ready-to-use platforms offer high-throughput solutions for organs-on-chip applications, facilitating advanced research in neurology, dermatology, and other fields crucial for disease study and drug discovery.

Moreover, the liver-on-a-chip segment is a significant driver of the organ-on-a-chip industry, driven by its key role in advancing biomedical research and drug development. For instance, in September 2023, CN Bio, a key player in the organ-on-a-chip industry, collaborated with LifeNet Health LifeSciences, a nonprofit organization recognized globally for its expertise in all-human research solutions. The collaboration aims to supply CN Bio's PhysioMimix OOC range with validated primary human cells from LifeNet Health. In this agreement, LifeNet Health provided supreme-quality, MPS-validated hepatic cells that can be accessed through CN Bio's 'in-a-box' kit for Non-Alcoholic Steatohepatitis (NASH), or directly from LifeNet Health.

Furthermore, North America dominated the organ-on-a-chip industry in 2023 and is projected to grow at the fastest CAGR over the forecast period. The growth is attributed to the presence of key market players in the region and government initiatives. For instance, in March 2023, Bayer AG collaborated with esqLABS and Dynamic42. They introduced a one-year organ-on-a-chip pilot program to reduce testing on animals for drug development in the healthcare industry. Such business initiatives are anticipated to contribute to the growth of the market of the North America region.

Organ-on-a-chip Market Report Highlights:

• The services segment accounted for the largest revenue share of 52.18% in 2024. Segment growth can be attributed to its ability to provide specialized expertise, cost-effectiveness, and comprehensive solutions.
• The drug discovery dominated the market with a revenue share of 62.78% in 2024 due to its key role in advancing preclinical testing.
• North America organ on a chip market has dominated the global market, with a revenue share of 51.97% in 2024.
• Asia Pacific organ-on-a-chip market is anticipated to grow at the fastest rate of 29.11% over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Products & Service Segment
  • 1.1.2. Application Segment
  • 1.1.3. End Use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Primary Research
• 1.6. Information or Data Analysis:
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Validation
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. List of Abbreviations
• 1.11. Objective

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing demand for personalized medicine
    • 3.2.1.2. Technological advancements in organ-on-a-chip technologies
    • 3.2.1.3. Increasing applications of organ-on-a-chip models in biomedical research
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Technical challenges and complexities associated with organ-on-a-chip technique
    • 3.2.2.2. Regulatory hurdles in organ-on-a-chip method
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Products & Service Group Business Analysis

• 4.1. Products & Service Segment Dashboard
• 4.2. Organ-on-a-Chip Market Products & Service Movement Analysis
• 4.3. Organ-on-a-Chip Market Size & Trend Analysis, by Products & Service, 2018 to 2030 (USD Million)
• 4.4. Products
  • 4.4.1. Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Instruments
    • 4.4.2.1. Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Organ-on-a-Chip Devices
    • 4.4.3.1. Organ-on-a-chip devices market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.2. Liver-on-a-Chip
      • 4.4.3.2.1. Liver-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.3. Lung-on-a-Chip
      • 4.4.3.3.1. Lung-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.4. Intestine-on-a-Chip
      • 4.4.3.4.1. Intestine-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.5. Kidney-on-a-Chip
      • 4.4.3.5.1. Kidney-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.6. Heart-on-a-Chip
      • 4.4.3.6.1. Heart-on-a-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.7. Others
      • 4.4.3.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Group Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Organ-on-a-Chip Market Application Movement Analysis
• 5.3. Organ-on-a-Chip Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Drug Discovery
  • 5.4.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Toxicology Research
  • 5.5.1. Toxicology research market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Organ-on-a-Chip Market End Use Movement Analysis
• 6.3. Organ-on-a-Chip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Pharmaceutical & Biotechnology Companies
  • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Academic & Research Institute
  • 6.5.1. Academic & research institute market estimates and forecasts, 2018-2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis by Products & Service, Application, End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
• 7.3. North America
  • 7.3.1. North America Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Target Disease Prevalence
    • 7.3.2.4. U.S. Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Target Disease Prevalence
    • 7.3.3.4. Canada Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Target Disease Prevalence
    • 7.3.4.4. Mexico Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Target Disease Prevalence
    • 7.4.2.4. UK Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Target Disease Prevalence
    • 7.4.3.4. Germany Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Target Disease Prevalence
    • 7.4.4.4. France Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Target Disease Prevalence
    • 7.4.5.4. Italy Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Target Disease Prevalence
    • 7.4.6.4. Spain Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Denmark Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Target Disease Prevalence
    • 7.4.8.4. Sweden Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Target Disease Prevalence
    • 7.4.9.4. Norway Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Japan Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. China Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Target Disease Prevalence
    • 7.5.4.4. India Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Target Disease Prevalence
    • 7.5.5.4. Australia Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Target Disease Prevalence
    • 7.5.6.4. Thailand Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.5.7. South Korea
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Target Disease Prevalence
    • 7.5.7.4. South Korea Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Target Disease Prevalence
    • 7.6.2.4. Brazil Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Target Disease Prevalence
    • 7.6.3.4. Argentina Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Target Disease Prevalence
    • 7.7.2.4. South Africa Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Target Disease Prevalence
    • 7.7.3.4. Saudi Arabia Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Target Disease Prevalence
    • 7.7.4.4. UAE Organ-on-a-Chip Market, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Target Disease Prevalence
    • 7.7.5.4. Kuwait Organ-on-a-Chip Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Emulate, Inc.
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. MIMETAS B.V.
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Valo Health
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Nortis, Inc.
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. AxoSim
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. BICO - THE BIO CONVERGENCE COMPANY
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. CN Bio Innovations Ltd
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. The Charles Stark Draper Laboratory, Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. SynVivo, Inc.
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. AlveoliX AG
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives